医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Temporal radiomics for non-invasive preoperative prediction of pathologic complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer

摘要Objective:This study aimed to develop and validate a temporal radiomics model based on pre-and post-treatment CT scans for the preoperative prediction of pathologic complete response(pCR)in patients with resectable non-small cell lung cancer(NSCLC)undergoing neoadjuvant chemoimmunotherapy(NCI).Methods:Data from 263 patients with resectable NSCLC who underwent NCI followed by curative surgery and had both pre-and post-treatment CT scans were retrospectively collected.Patients from one hospital were randomly divided into training and internal test sets at a 7:3 ratio,while patients from two other hospitals served as the external test set.Radiomics features were extracted from the CT scans at both timepoints and delta features capturing the temporal changes were calculated.Radiomics models based on different features were developed using the least absolute shrinkage and selection operator for feature selection,followed by logistic regression.Model performance was evaluated using the area under the curve(AUC).Results:The radiomics model based on delta features yielded AUCs of 0.85,0.76,and 0.72 in the training,internal test,and external test sets,respectively,which were superior to the radiomics models based on pre-treatment features(0.74,0.66,and 0.62,respectively)and post-treatment features(0.80,0.76,and 0.65,respectively).By integrating the optimal features from all three feature sources,the combined model achieved further improvements in performance,with AUCs of 0.89,0.85,and 0.78,respectively,across the three sets.Conclusions:A CT-based radiomics model incorporating temporal features from pre-and post-treatment scans shows favorable performance for the non-invasive preoperative estimation of pCR to NCI in patients with NSCLC.

更多
广告
作者 Sunyi Zheng [1] Shuo Wang [2] Ziwei Feng [3] Jing Liang [1] Jiaxin Liu [1] Xiaomeng Yang [1] Zhanshuo Zhang [2] Yuechen Cui [2] Jiping Xie [2] Shuxuan Fan [1] Jing Wang [4] Guoqing Liao [5] Haiyu Zhou [5] Zhaoxiang Ye [1] Jianyu Xiao [1] Lei Shi [6] Xiaonan Cui [1] Dongsheng Yue [2] 学术成果认领
作者单位 Department of Radiology,Medical Artificial General Intelligence for Computation(MAGIC)Lab,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine,Tianjin Key Laboratory of Digestive Cancer,Tianjin Key Laboratory of Cancer Prevention and Therapy,Tianjin Medical University Cancer Institute and Hospital,Tianjin 300060,China [1] Department of Lung Cancer,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center of Cancer,Lung Cancer Center,Tianjin Medical University Cancer Institute and Hospital,Tianjin 300060,China [2] National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute and Hospital,Tianjin 300060,China [3] School of Public Health,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China [4] Department of Thoracic Surgery,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Southern Medical University,Guangzhou 510060,China [5] Department of Radiology,Zhejiang Cancer Hospital,Hangzhou 310022,China [6]
栏目名称
DOI 10.20892/j.issn.2095-3941.2025.0327
发布时间 2026-04-15(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览1
  • 下载0
癌症生物学与医学(英文版)

癌症生物学与医学(英文版)

2026年23卷2期

294-309页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷